BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 223 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,509 | -18.6% | 100,000 | 0.0% | 0.01% | -16.7% |
| Q1 2024 | $3,081 | -25.8% | 100,000 | 0.0% | 0.01% | -33.3% |
| Q4 2023 | $4,154 | +53.7% | 100,000 | 0.0% | 0.01% | +50.0% |
| Q3 2023 | $2,702 | +58.8% | 100,000 | 0.0% | 0.01% | +50.0% |
| Q2 2023 | $1,702 | -0.3% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,707 | +357.6% | 100,000 | +100.0% | 0.00% | +300.0% |
| Q4 2022 | $373 | -99.9% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $500,000 | +45.3% | 50,000 | +25.6% | 0.00% | 0.0% |
| Q2 2022 | $344,000 | -16.7% | 39,800 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $413,000 | -20.1% | 39,800 | +9.9% | 0.00% | 0.0% |
| Q4 2021 | $517,000 | -68.6% | 36,200 | +2.8% | 0.00% | -80.0% |
| Q3 2021 | $1,648,000 | -47.3% | 35,200 | -33.8% | 0.01% | -44.4% |
| Q2 2021 | $3,130,000 | +1.3% | 53,200 | 0.0% | 0.01% | -10.0% |
| Q1 2021 | $3,089,000 | +21.4% | 53,200 | +39.3% | 0.01% | 0.0% |
| Q4 2020 | $2,545,000 | +75.5% | 38,200 | -4.7% | 0.01% | +66.7% |
| Q3 2020 | $1,450,000 | – | 40,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $373,797,000 | 67.28% |
| Darwin Global Management, Ltd. | 2,090,149 | $128,753,000 | 25.21% |
| Affinity Asset Advisors, LLC | 577,500 | $35,574,000 | 12.08% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $1,913,356,000 | 9.64% |
| Perceptive Advisors | 7,756,928 | $477,827,000 | 6.04% |
| Opaleye Management Inc. | 583,767 | $35,960,000 | 5.28% |
| MIZUHO MARKETS AMERICAS LLC | 171,923 | $10,590,000 | 4.93% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $1,639,853,000 | 4.88% |
| Fernwood Investment Management, LLC | 151,085 | $9,307,000 | 3.42% |
| HHLR ADVISORS, LTD. | 5,362,014 | $330,300,000 | 3.26% |